zedie.wordpress.com
Alfacalcidol Does Not Lower CV Risk in Dialysis, Trial Suggests
Alfacalcidol does not reduce the risk for cardiovascular events in patients without secondary hyperparathyroidism undergoing maintenance hemodialysis compared with usual care, the Japan Dialysis Ac…